HIGH-DOSE CYTOSINE-ARABINOSIDE (HDARA-C) AND DAUNORUBICIN (DNR) AS INITIAL THERAPY IN ADULT ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL)

被引：0
|
作者：
REECE, D
SHEPHERD, J
PHILLIPS, G
HERZIG, R
BUSKARD, N
BENNY, B
GROWE, G
VICKARS, L
HERZIG, G
机构：
[1] LEUKEMIA BMT PROGRAM BRITISH COLUMBIA,VANCOUVER,BC,CANADA
[2] WASHINGTON UNIV,ST LOUIS,MO 63130
[3] CLEVELAND CLIN,CLEVELAND,OH 44106
来源：
CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE | 1987年 / 10卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：B81 / B81
页数：1
相关论文
共 50 条
  • [21] HIGH-DOSE CYTOSINE-ARABINOSIDE IN THE INITIAL TREATMENT OF ACUTE-LEUKEMIA
    BARNETT, MJ
    WAXMAN, JH
    RICHARDS, MA
    GANESAN, TS
    BRAGMAN, KS
    ROHATINER, AZS
    LISTER, TA
    SEMINARS IN ONCOLOGY, 1985, 12 (02) : 133 - 138
  • [22] CELL KINETIC RESPONSES IN CHILDHOOD ACUTE NONLYMPHOCYTIC LEUKEMIA DURING HIGH-DOSE THERAPY WITH CYTOSINE-ARABINOSIDE
    SMETS, LA
    TAMINIAU, J
    HAHLEN, K
    DEWAAL, F
    BEHRENDT, H
    BLOOD, 1983, 61 (01) : 79 - 84
  • [23] HIGH-DOSE CYTOSINE-ARABINOSIDE AND M-AMSA IS EFFECTIVE THERAPY IN RELAPSED ACUTE NONLYMPHOCYTIC LEUKEMIA
    HINES, JD
    OKEN, MM
    MAZZA, JJ
    KELLER, AM
    STREETER, RR
    GLICK, JH
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) : 545 - 549
  • [24] HIGH-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ADULT ACUTE MYELOGENOUS LEUKEMIA
    NEMET, D
    LABAR, B
    BOGDANIC, V
    HAUPTMAN, E
    JAKSIC, B
    MINIGO, H
    SERTIC, D
    MRSIC, M
    PAVLETIC, Z
    KOVACEVIC, J
    ZUPANCICSALEK, S
    RADMAN, I
    BONE MARROW TRANSPLANTATION, 1989, 4 : 42 - 44
  • [25] ADRIAMYCIN OR DAUNORUBICIN IN COMBINATION WITH CYTOSINE-ARABINOSIDE FOR THE TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA
    WIERNIK, PH
    RIGGS, C
    DUTCHER, JP
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1983, 9 (06) : 403 - 406
  • [26] HIGH-DOSE CYTOSINE-ARABINOSIDE THERAPY FOR REFRACTORY LEUKEMIA
    FEY, M
    BLOOD, 1984, 64 (03) : 758 - 759
  • [27] HIGH-DOSE CYTOSINE-ARABINOSIDE THERAPY FOR REFRACTORY LEUKEMIA
    HERZIG, RH
    WOLFF, SN
    LAZARUS, HM
    PHILLIPS, GL
    KARANES, C
    HERZIG, GP
    BLOOD, 1983, 62 (02) : 361 - 369
  • [28] THE ROLE OF TIMING OF HIGH-DOSE CYTOSINE-ARABINOSIDE INTENSIFICATION AND OF MAINTENANCE THERAPY IN THE TREATMENT OF CHILDREN WITH ACUTE NONLYMPHOCYTIC LEUKEMIA
    WOODS, WG
    RUYMANN, FB
    LAMPKIN, BC
    BUCKLEY, JD
    BERNSTEIN, ID
    SRIVASTAVA, AK
    SMITHSON, WA
    BENJAMIN, DR
    FEIG, SA
    KIM, TH
    ODOM, LF
    WELLS, RJ
    HAMMOND, GD
    CANCER, 1990, 66 (06) : 1106 - 1113
  • [29] HIGH-DOSE CYTOSINE-ARABINOSIDE AS THE INITIAL TREATMENT OF POOR-RISK PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA - A LEUKEMIA INTERGROUP STUDY
    PREISLER, HD
    RAZA, A
    BARCOS, M
    AZARNIA, N
    LARSON, R
    WALKER, I
    BROWMAN, M
    GRUNWALD, H
    DARRIGO, P
    DOEBLIN, T
    BLOOM, M
    STEIN, A
    LOGUE, G
    GOLDBERG, J
    KIRSHNER, J
    GOTTLIEB, A
    BENNETT, J
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (01) : 75 - 82
  • [30] HIGH-DOSE CYTOSINE-ARABINOSIDE (HDARA-C) FOR THE MANAGEMENT OF CENTRAL-NERVOUS-SYSTEM DISEASE IN ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AND NON-HODGKINS-LYMPHOMA
    LAZZARINO, M
    MORRA, E
    BRUSAMOLINO, E
    INVERARDI, D
    PAGNUCCO, G
    CANEVARI, A
    ORLANDI, E
    BERNASCONI, C
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1987, 3 (01): : 51 - 57
12345